Healthcare -
Biotechnology - NASDAQ - US
$ 8.16
-8.36 %
$ 310 M
Market Cap
4.96
P/E
TRDA - TOTAL EQUITY
Total Equity TRDA - Entrada Therapeutics, Inc.
429 M
LAST VALUE
42.01%
2 YEAR CAGR
96.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR